The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.
Study Type
OBSERVATIONAL
Enrollment
588
Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance.
University Clinic of Erlangen Nuernberg
Erlangen, Germany
Handling of Daivobet® Gel
Compared to previous topical treatment: Time required for application (previous treatment versus present treatment), time required until dressing is possible (previous treatment versus present treatment)
Time frame: After appr 4 weeks
Quality of life
Dermatology Life Quality Index (DLQI)
Time frame: 4 weeks
Physician's global Assessment of psoriasis vulgaris
6-step scale from "no visible disease (O)" to "very severe disease (5)
Time frame: 4 weeks
Side effects
number of participants with serious and non-serious adverse drug reactions, according to organ classes
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.